With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
The May / June 2005 Edition of Health Affairs is devoted to the financing of vaccines. The full articles are only available to subscribers.
The editorial says:
Because poor countries lack the resources, little research and development is conducted on vaccines for diseases that primarily affect them. In the past several years, momentum has been building around an idea that if purchasers would commit, in advance of product development, to pay for vaccines at a fixed, predetermined price, it would eliminate economic uncertainty for vaccine manufacturers and guarantee a market. Ernst Berndt and John Hurvitz describe this novel approach, which is gaining support among governments and private organizations. Other papers with international dimensions include those by Tracy Lieu and colleagues, who point out that collaborations engaging private philanthropy and governments have led to increased uses of vaccines in developing countries; an action plan for maximizing access to needed vaccines in low-income countries by Julie Milstien and colleagues; a view by David Salisbury on how the U.K. National Health Service manages vaccines; and a review by Robert Northrup of a book by Ruth Levine and others that details diverse stories of success in addressing health problems in the developing world.
Last week, Gavi, the Vaccine Alliance, completed a $7.5 billion replenishment to fund its work on immunization in the world’s poorest countries between now and 2020. Gavi’s next step is to ensure that the money is used as effectively as possible to save lives and improve health.